Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (2): 268-271    DOI: 10.12891/ceog3047.2017
Original Research Previous articles | Next articles
Deep infiltrating endometriosis in young women
M. Zu1, W. Meng2, Q.Z. Guo1, Z.Q. Liu1, *()
1 Department of Gynecology and Obstetrics, Section of Clinical Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, China
2 Department of Central Laboratory, Section of Preclinical Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, China
Download:  PDF(75KB)  ( 68 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
This work aimed to analyze the effect of deep infiltrating endometriosis (DIE) in young women. Twenty-seven cases of patients (below 38-years-old) diagnosed with DIE and admitted to the present hospital from January 2008 to July 2014 were reviewed, and their pre- and postoperative states of illness were summarized. The main preoperative symptoms included dysmenorrhea, chronic pelvic pain, dyspareunia, nodule in rectouterine fossa, and reduced level of fertility. All patients underwent surgery (17 laparoscopies and ten laparotomies). Postoperative pathological explanation confirmed DIE in lesions. DIE significantly affects the health of young women.
Key words:  Deep infiltrating endometriosis      Dysmenorrhea      Dyspareunia     
Published:  10 April 2017     
*Corresponding Author(s):  Z.Q. LIU     E-mail:  doctorliuzhiqiang@163.com

Cite this article: 

M. Zu, W. Meng, Q.Z. Guo, Z.Q. Liu. Deep infiltrating endometriosis in young women. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 268-271.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3047.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I2/268

[1] Maria Aparecida Mazzutti Verlangieri Carmo, Helmer Herren, Francisco J. C. Dos-Reis, Fabricio Da Silva Costa, Julio C. Rosa-e-Silva, Antonio Alberto Nogueira, Omero Benedicto Poli-Neto. Reliability and agreement of three-dimensional/four-dimensional transperineal ultrasound in women with chronic pelvic pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 494-499.
[2] D. Filipecka-Tyczka, A. Kajdy, B.P. Siekierski, M. Stańczyk, A. Rogowski, M. Rabijewski, R.B. Maksym. Deep infiltrating endometriosis as a cause of severe urogynecological complications despite invasive treatment - report of two cases from the center of endometriosis surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 955-960.
[3] J.H. Check, D. Check, R. Cohen. A novel effective treatment for menière’s disease – dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 807-809.
[4] H. Kwon, J.E. Shin, H. Kim. A novel treatment of severe dysmenorrhea due to adenomyosis: a case series of 3 infertile patients treated with dopamine agonist and in vitro fertilization-embryo transfer resulting in successful pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 637-640.
[5] M. C. Teodoro, G. Scibilia, E. Lomeo, B. Pecorino, A. Galia, P. Scollo. Carbon dioxide laser as a new valid treatment of lichen sclerosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 206-210.
[6] Ju-Qi Ma, Chun-Fen Guo, Ayshamgul Hasim. Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 387-390.
[7] G. Sukgen, A. Altunkol, D. Abat. Comparison between four- and six-arm pelvic organ polypropylene mesh implantation for the treatment of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 414-418.
[8] L. Roncati, T. Pusiol. Arteriovenous malformations (AVM) of the corpus uteri[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 764-766.
[9] M. Temur, U. Gök Balci, Y. A. Güçlü, B. Korkmaz, P.Ö. Özbay, N. Soysal, Ö. Yilmaz, T.T. Yilmazer, T. Çift, K. Öngel. Does increase in body mass index effect primary dysmenorrhea?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 777-781.
[10] R. M. F. Daher, J. C. Rosa-e-Silva, O. B. Poli-Neto, F. J. Candido-dos-Reis, A. A. Nogueira. Diagnosis of endometriosis in women with chronic pelvic pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 512-515.
[11] S. J. Liu, W. Lv. A laparoscopic surgery for deep infiltrating endometriosis and the review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 616-618.
[12] Fei Ji, Xin-Hua Yang, AiXingZi. AiLi, HaNiKeZi. TuerXun, Yan He, Yan Ding. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 677-680.
[13] A. Imai, K. Matsunami, H. Takagi, S. Ichigo. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 495-498.
[14] B. Artunc Ulkumen, M.M. Erkan, H.G. Pala, Y. Bulbul Baytur. Sexual dysfunction in Turkish women with dyspareunia and its impact on the quality of life[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 567-571.
[15] J.H. Check, R. Cohen. The triad of luteal phase ocular migraines, interstitial cystitis, and dyspareunia as a result of sympathetic nervous system hypofunction[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 575-577.
No Suggested Reading articles found!